CompanyTrack
B

BIOSCRIPT LIMITED

Active Macclesfield

Activities of other holding companies n.e.c.

13 employees Website
Life sciences and medical technology Activities of other holding companies n.e.c.
B

BIOSCRIPT LIMITED

Activities of other holding companies n.e.c.

Founded 22 Feb 2021 Active Macclesfield, England 13 employees bioscriptgroup.com
Life sciences and medical technology Activities of other holding companies n.e.c.
Accounts Submitted 27 Jun 2025
Confirmation Statement Submitted 6 Feb 2025
Net assets £-26.33M £8.38M 2024 year on year
Total assets £0.00 £60.19M 2024 year on year
Total Liabilities £48.79M £29.34M 2024 year on year
Charges 1
1 outstanding

AI Analysis

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Registered Address

Suite A, Greenway House Larkwood Way Tytherington Business Park Macclesfield SK10 2XR England

Office (Macclesfield)

Nether Alderley, Macclesfield SK10 4EL

Office (UK)

The Ropewalks Newton Street Macclesfield Cheshire SK11 6QJ

Office (USA)

103 Carnegie Center Suite 300 Princeton, NJ 08540 6235

Credit Report

Discover BIOSCRIPT LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2021–2024)

Cash in Bank

£41.09k

Increased by £37.51k (+1049%)

Net Assets

-£26.33M

Decreased by £8.38M (-47%)

Total Liabilities

£48.79M

Decreased by £29.34M (-38%)

Turnover

£1.14M

Decreased by £132.59k (-10%)

Employees

13

Increased by 2 (+18%)

Debt Ratio

N/A

Decreased by 130 (-100%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

4 Allotments 120,095,621 Shares £4.02m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
26 Apr 202490,000,000£900k£0.01
29 Sept 202229,999,420£300k£0.01
30 Jul 20211£23k£23k
2 Mar 202196,200£2.80m£29.114

Officers

Officers

2 active 5 resigned
Status
Gabrielle Alison SilverDirectorBritishEngland522 May 2023Active
James MaxwellDirectorBritishUnited Kingdom4115 Feb 2024Active

Shareholders

Shareholders (1)

Bioscript Midco 2 Limited
100.0%
522,342,8296 Feb 2025

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Bioscript Midco 2 Limited

United Kingdom

Active
Notified 22 Feb 2021
Nature of Control
  • Ownership Of Shares 75 To 100 Percent
  • Voting Rights 75 To 100 Percent
  • Right To Appoint And Remove Directors

Group Structure

Group Structure

BIOSCRIPT MIDCO 2 LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
BIOSCRIPT MIDCO 1 LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
BIOSCRIPT HOLDINGS LIMITED united kingdom significant influence or control
BB SHELF 4 LLP united kingdom voting rights 75 to 100 percent limited liability partnership
BIOSCRIPT LIMITED Current Company
AZIMUTH PHARMA LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
BIOSCRIPT GROUP LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
ENZYME COMMUNICATIONS LTD united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
MERIDIAN HEALTHCOMMS HOLDINGS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
VALID INSIGHT LTD united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

Charges

Charges

1 outstanding

Documents

Company Filings

DateCategoryDescriptionDocument
27 Jun 2025AccountsAnnual accounts made up to 2024-09-30View(30 pages)
7 Feb 2025OfficersChange to director Mr James Maxwell on 2025-02-06View(2 pages)
6 Feb 2025Confirmation StatementConfirmation statement made on 2025-01-23 with updatesView(5 pages)
1 Oct 2024OfficersChange to director Dr Gabrielle Alison Silver on 2024-09-24View(2 pages)
1 Oct 2024Persons With Significant ControlChange to Bioscript Midco 2 Limited as a person with significant control on 2024-09-24View(2 pages)
27 Jun 2025 Accounts

Annual accounts made up to 2024-09-30

7 Feb 2025 Officers

Change to director Mr James Maxwell on 2025-02-06

6 Feb 2025 Confirmation Statement

Confirmation statement made on 2025-01-23 with updates

1 Oct 2024 Officers

Change to director Dr Gabrielle Alison Silver on 2024-09-24

1 Oct 2024 Persons With Significant Control

Change to Bioscript Midco 2 Limited as a person with significant control on 2024-09-24

Recent Activity

Latest Activity

Annual accounts made up to 2024-09-30

7 months ago on 27 Jun 2025

Change to director Mr James Maxwell on 2025-02-06

1 years ago on 7 Feb 2025

Confirmation statement made on 2025-01-23 with updates

1 years ago on 6 Feb 2025

Change to director Dr Gabrielle Alison Silver on 2024-09-24

1 years ago on 1 Oct 2024

Change to Bioscript Midco 2 Limited as a person with significant control on 2024-09-24

1 years ago on 1 Oct 2024